Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine (ERIEAS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04110626|
Recruitment Status : Not yet recruiting
First Posted : October 1, 2019
Last Update Posted : October 1, 2019
|Condition or disease||Intervention/treatment|
|Addiction||Other: Questionnaires Other: Non-directive Interviews|
- Alcohol consumption represents the second main modifiable risk factor for cancer and the second preventable mortality cause in France, after tobacco use. It is mainly during adolescence, which corresponds to a period of integration with peers and a period of detachment from parents, that alcohol use starts. In France, alcohol remains the substance that adolescents most experiment with. A 2014 report shows that nearly half (49.4%) of first-year secondary school pupils have already tried an alcoholic drink and about one in seven secondary school pupils' reports having been drunk. The impact of cannabis consumption is wide as it can affect the social environment, the brain and the psychology of the consumers. Adolescence is a period during which the brain undergoes profound remodelling in areas that are high in cannabinoid receptors and that mediate cognitive control and emotion regulation. Therefore, childhood and adolescence are important stages of life on which preventive efforts may be focused, also because events occurring in the earliest stages of human development (before birth and during childhood) are known to be related to further risk for cancer, other chronic diseases and adult conditions.
- Among addiction prevention programmes, those that focus on life skills have been mentioned in the literature as being effective. In this context, the French organization "Association Ressources et Initiatives Addictions" (ARIA) has developed Expériences Animées programme (animated experiences) based on the above features, with the aim to help adolescents to change their representations and strengthen their life skills. This is a grassroots innovation. It has to be evaluated.
- The Expériences Animées programme involves supervised short movies and talks with secondary and high school pupils about the use of psychoactive substances. The movies are made specifically for the programme. The sessions are facilitated by two professionals including at least a clinical psychologist. In a given secondary/high school, one session per term is delivered for each class (40 classes). Three to five films are shown at each session. Each film aims to work on 2 to 3 life skills allowing to build protective behaviors against addictions. This programme is implemented since 2015.
- The investigators will collect quantitative and qualitative data to appraise the outcomes (O), mechanisms (M) and contextual elements (C), including the interventional elements) in order to verify the initial theories (hypothesis of causal pathways) by i) Questionnaires to collect outcomes in terms of consumption and health care, and some mechanisms: 2/ Non-directive interviews to collect mechanisms and contextual factors 3/ Observations to collect contextual elements during the sessions. The investigators will design the survey instruments in line with the initial middle-range theories identified.
|Study Type :||Observational|
|Estimated Enrollment :||1200 participants|
|Official Title:||Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine|
|Estimated Study Start Date :||September 30, 2019|
|Estimated Primary Completion Date :||June 2022|
|Estimated Study Completion Date :||June 2022|
Expériences Animées Programme
The Expériences Animées programme involves supervised short movies and talks with secondary school and high school pupils about the use of psychoactive substances.
The questionnaires are completed at the 3 survey times (T0, T1 and T2) by all pupils involved. Collected data are quantitative
Other: Non-directive Interviews
The interviews are conducted with 80 pupils/year randomly selected (i.e. 2 per class and 8 per establishment/year). Collected data are qualitative
- Daily, alcohol consumption [ Time Frame: 3 years ]Alcohol consumption per day at study entry, after 1 year and after 2 years
- Weekly, alcohol consumption [ Time Frame: 3 years ]Alcohol consumption per week at study entry, after 1 year and after 2 years
- Monthly, alcohol consumption [ Time Frame: 3 years ]Alcohol consumption per month at study entry, after 1 year and after 2 years
- Number of episodes of heavy drinking [ Time Frame: 3 years ]An episode of heavy drinking : at least 5 drinks per occasion at study entry, after 1 year and after 2 years
- Number of drunkenness episodes [ Time Frame: 3 years ]Number of episodes at study entry, after 1 year and after 2 years
- Weekly, cannabis consumption [ Time Frame: 3 years ]Number of cannabis consumption per week at study entry, after 1 year and after 2 years
- Monthly, cannabis consumption [ Time Frame: 3 years ]Number of cannabis consumption per month at study entry, after 1 year and after 2 years
- Yearly, cannabis consumption [ Time Frame: 3 years ]Number of cannabis consumption per year at study entry, after 1 year and after 2 years
- Number of consultation of a healthcare professional to discuss about a problematic use of alcohol and/or cannabis [ Time Frame: 3 years ]Number of times at study entry, after 1 year and after 2 years
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04110626
|Contact: Linda CAMBON||(0)557571769 ext +33||Linda.email@example.com|
|Contact: Judith MARTIN||(0)557571043 ext +firstname.lastname@example.org|
|CIC1401-EC - CHU de Bordeaux Centre Inserm U1219|
|Bordeaux, France, 33000|
|Contact: Linda CAMBON (0)557571769 ext +33 email@example.com|
|Contact: Judith MARTIN (0)557571043 ext +33 firstname.lastname@example.org|
|Principal Investigator: François ALLA, MD PhD|
|Principal Investigator:||François ALLA, MD PhD||CIC1401-EC, Inserm-CHU de Bordeaux|